tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CHRS Stock Latest News

Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
RatingsCoherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
11d ago
CHRS
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
PremiumThe Fly
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
13d ago
CHRS
Coherus Biosciences Divests UDENYCA Business
PremiumCompany Announcements
Coherus Biosciences Divests UDENYCA Business
1M ago
8K
CHRS
Coherus Oncology files $150M mixed securities shelf
PremiumThe Fly
Coherus Oncology files $150M mixed securities shelf
1M ago
CHRS
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
PremiumCompany Announcements
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
1M ago
CHRS
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
PremiumRatingsOptimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
1M ago
CHRS
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
Premium
Ratings
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
1M ago
CHRS
Coherus Biosciences announces data from Phase 1b trial of CHS-114
Premium
The Fly
Coherus Biosciences announces data from Phase 1b trial of CHS-114
1M ago
CHRS
Coherus Oncology Reports Q3 2025 Financial Results
PremiumCompany Announcements
Coherus Oncology Reports Q3 2025 Financial Results
1M ago
CHRS
Coherus Biosciences reports Q3 EPS (33c), consensus (29c)
PremiumThe Fly
Coherus Biosciences reports Q3 EPS (33c), consensus (29c)
1M ago
CHRS
CHRS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CHRS Upcoming Earnings Report: What to Expect?
2M ago
CHRS
Coherus Biosciences: Buy Rating Backed by Innovative Oncology Pipeline and Strategic Transition
PremiumRatings
Coherus Biosciences: Buy Rating Backed by Innovative Oncology Pipeline and Strategic Transition
2M ago
CHRS
Coherus Biosciences Regains Nasdaq Compliance
PremiumCompany AnnouncementsCoherus Biosciences Regains Nasdaq Compliance
3M ago
8K
CHRS
Black Diamond, TransMedics, Duolingo, AT&T, Coherus: Trending by Analysts
Premium
Weekend Updates
Black Diamond, TransMedics, Duolingo, AT&T, Coherus: Trending by Analysts
4M ago
T
BDTX
Coherus Biosciences upgraded to Buy from Neutral at Roth Capital
Premium
The Fly
Coherus Biosciences upgraded to Buy from Neutral at Roth Capital
4M ago
CHRS
Coherus Biosciences upgraded to Buy from Hold at Maxim
PremiumThe Fly
Coherus Biosciences upgraded to Buy from Hold at Maxim
4M ago
CHRS
Coherus Oncology’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Coherus Oncology’s Earnings Call Highlights Growth and Challenges
4M ago
CHRS
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
PremiumRatings
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
4M ago
CHRS
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
PremiumRatings
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
4M ago
CHRS
Coherus Oncology Reports Strong Q2 2025 Growth
PremiumCompany AnnouncementsCoherus Oncology Reports Strong Q2 2025 Growth
4M ago
CHRS
Coherus Biosciences reports Q2 EPS (39c), consensus (27c)
Premium
The Fly
Coherus Biosciences reports Q2 EPS (39c), consensus (27c)
5M ago
CHRS
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >